Healthcare stocks offer stability and growth, driven by rising healthcare needs, innovation, and government focus on health infrastructure. Investing in fundamentally strong healthcare companies ensures exposure to sectors like pharmaceuticals, diagnostics, hospitals, and medical devices, offering long-term potential.
These stocks are supported by robust financials, scalable business models, and competitive advantages. As India’s healthcare industry expands, driven by rising demand and export opportunities, tracking well-managed companies with proven performance is essential for sustainable investment growth.
Also Read: Telecom stock jumps 14% after it receives order worth ₹41 Cr from Tata group
Max Healthcare
On January 10, 2025, Max Healthcare Institute Ltd. opened at ₹1,195.65, down 1.14% from its previous close of ₹1,209.45. The stock reached a high of ₹1,212.20 and a low of ₹1,146.00. By 4:00 PM, it traded at ₹1,149.00, a 5.00% decrease, with a market cap of ₹1,11,697.97 crore.
Max Healthcare Institute Ltd (NSE: MAXHEALTH) is a leading healthcare provider offering services through primary care clinics, multi-specialty hospitals, and super-specialty facilities. It also manages third-party healthcare facilities through long-term service contracts, covering various medical services.
Max Healthcare Institute Ltd. demonstrates strong financial performance with a Return on Capital Employed (ROCE) of 16.0% and a Return on Equity (ROE) of 13.4%. The company maintains a low debt-to-equity ratio of 0.20, reflecting solid financial stability and efficient capital management.
Krsnaa Diagnostics
On January 10, 2025, Krsnaa Diagnostics Ltd. opened at ₹892.05, down 0.63% from its previous close of ₹897.70. The stock reached a high of ₹892.05 and a low of ₹853.90. By 4:00 PM, it traded at ₹862.85, a 3.88% decrease, with a market cap of ₹2,786.12 crore.
Krsnaa Diagnostics Ltd. exhibits solid financial health with a Return on Capital Employed (ROCE) of 10.1% and a Return on Equity (ROE) of 7.52%. The company maintains a low debt-to-equity ratio of 0.25, indicating strong financial stability and prudent capital management.
Krsnaa Diagnostics Ltd. (NSE: KRSNAA) is a leading technology-enabled diagnostic services provider in India, offering imaging, pathology, and teleradiology services. It has a significant presence in both private and public healthcare sectors across non-metro cities and towns.
Also Read: EMS stock in focus after company to manufacture MSI laptops for India
Apollo Hospitals
On January 10, 2025, Apollo Hospitals Enterprise Ltd. opened at ₹7,124.35, up 0.49% from its previous close of ₹7,089.85. The stock reached a high of ₹7,132.40 and a low of ₹7,019.00. By 4:00 PM, it traded at ₹7,043.00, a 0.66% decrease, with a market cap of ₹1,01,267.53 crore.
Apollo Hospitals Enterprise Ltd. demonstrates strong financial performance with a Return on Capital Employed (ROCE) of 15.1% and a Return on Equity (ROE) of 13.3%. The company maintains a debt-to-equity ratio of 0.98, reflecting balanced capital structure and robust financial management.
Apollo Hospitals Enterprises Ltd (NSE: APOLLOHOSP) is a leading integrated healthcare provider in Asia. Established in 1983, it pioneered private healthcare in India, offering a wide range of services including hospitals, pharmacies, clinics, and retail health models.
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.
